Results 31 to 40 of about 6,540 (205)

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis

Health Technology Assessment, 2023
Background Cascade testing the relatives of people with familial hypercholesterolaemia is an efficient approach to identifying familial hypercholesterolaemia.
Nadeem Qureshi, Bethan Woods, Rita Neves de Faria, Pedro Saramago Goncalves, Edward Cox, Jo Leonardi-Bee, Laura Condon, Stephen Weng, Ralph K Akyea, Barbara Iyen, Paul Roderick, Steve E Humphries, William Rowlands, Melanie Watson, Kate Haralambos, Ryan Kenny, Dev Datta, Zosia Miedzybrodzka, Christopher Byrne, Joe Kai   +19 more
doaj   +1 more source

Lipemia retinalis in a 35-day-old infant with hyperlipoproteinemia: case report [PDF]

, 2008
A rare case of hyperlipropoteinemia in a 35-day-old infant who presented not only high blood levels of cholesterol and triglycerides but also an ocular manifestation described as lipemia retinalis.
Ayhara, Teruo, Cypel, Marcela, Ishida, Noemi, Manzano, Roberta, Reis, Frederico Augusto dos   +4 more
core   +2 more sources

Ghrelin Levels in Male Patients with Hyperlipoproteinemia I, II versus Type 2 Diabetes Mellitus.

مجلة كلية الطب, 2014
Background; Hyperlipoproteinemia (HLP)  are divided in primary and secondary subtypes. Primary HLP is usually due to genetic causes. Secondary HLP is resulting from another underlying disorder such as diabetes mellitus that leads to alterations in plasma
Salma A. Abbas, Samir L. Shkhaier, Baydaa A. Abed   +2 more
doaj   +1 more source

Two-year outcomes of a cardiac microcurrent device in chronic heart failure: A first-in-human pilot study. [PDF]

ESC Heart Fail
Abstract Aims In heart failure patients, altered myocardial electrical fields linked to oedema may impair left ventricular function. While short‐term use of implanted microcurrent generators (C‐MIC) has shown promise, long‐term effects remain unclear.
Kosevic DB, Radak U, Vukovic P, Schmitto JD, Brandes K, Goettel P, Duengen HD, Tahirovic E, Zdravkovic M, Mueller J, Kallel F, Fudim M, Anker SD, Rame JE, Peric M.   +14 more
europepmc   +2 more sources

Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.

Journal of Lipid Research, 1988
Apolipoprotein (apo) C-II deficiency is characterized by elevated plasma triglycerides, chylomicrons, and very low density lipoproteins, as well as reduced levels of low density and high density lipoproteins.
D L Sprecher, L Taam, R E Gregg, S S Fojo, D M Wilson, M L Kashyap, H B Brewer, Jr   +6 more
doaj   +1 more source

Decreased plasma postheparin lipolytic activity in systemic lupus erythematosus [PDF]

, 1977
Plasma postheparin lipolytic activity (PHLA) was measured on 50 patients with systemic lupus erythematosus (SLE). Plasma PHLA was significantly decreased in SLE patients. This decrease was most striking in the acute phase of the disease.
Kawanishi, Koichi, Nagase, Masayuki, Ofuji, Tadashi, Ueda, Hidenori   +3 more
core   +1 more source

Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes

Journal of Lipid Research, 1999
Type III hyperlipoproteinemia (HLP) is a genetic disorder characterized by accumulation of remnant lipoproteins in the plasma and development of premature atherosclerosis. Although receptor binding-defective forms of apolipoprotein (apo) E are the common
Robert W. Mahley, Yadong Huang, Stanley C. Rall, Jr.   +2 more
doaj   +1 more source

Coronary Artery Bypass Grafting on Microaxial Flow Pump Support in Patients With Severely Reduced Left Ventricular Ejection Fraction. [PDF]

Artif Organs
Coronary artery revascularization with microaxial flow pump support in patients with severely reduced left ventricular ejection fraction is an emerging technique in cardiac surgery. In this manuscript, we present early results, highlight the advantages, and discuss the key limitations of this approach.
Nersesian G, Lewin D, Hrytsyna Y, Lanmueller P, Ott S, Merke N, Falk V, Schoenrath F, Potapov E, Abd El Al A.   +9 more
europepmc   +2 more sources

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. [PDF]

, 2016
Apolipoprotein (apo) E was initially described as a lipid transport protein and major ligand for low density lipoprotein (LDL) receptors with a role in cholesterol metabolism and cardiovascular disease.
Mahley, Robert W
core   +1 more source

Hepatic cholesterol metabolism in normo- and hyperlipidemic patients with cholesterol gallstones.

Journal of Lipid Research, 1979
In vivo studies have shown abnormalities in cholesterol and bile acid metabolism in primary hyperlipoproteinemia (HLP). The aim of the present investigation was to determine if the increased production of cholesterol in HLP type IV can be attributed to a
J Ahlberg, B Angelin, I Björkhem, K Einarsson, B Leijd   +4 more
doaj   +1 more source